Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2009

01-01-2009 | Head and Neck Oncology

Risk Stratification of Patients with Oral Cavity Squamous Cell Carcinoma and Contralateral Neck Recurrence Following Radical Surgery

Authors: Chun-Ta Liao, Shiang-Fu Huang, I-How Chen, Joseph Tung-Chieh Chang, Hung-Ming Wang, Shu-Hang Ng, Chuen Hsueh, Li-Yu Lee, Chih-Hung Lin, Ann-Joy Cheng, Tzu-Chen Yen

Published in: Annals of Surgical Oncology | Issue 1/2009

Login to get access

Abstract

Clinical outcome of patients with oral cavity squamous cell carcinoma (OSCC) and contralateral neck recurrence (CLNR) remains poor. We sought to identify factors associated with CLNR and incorporate them into a risk stratification scheme. Between January 1996 and June 2006, a total of 913 consecutive OSCC patients treated by radical surgery were investigated. Postoperative adjuvant therapy was performed in the presence of pathological risk factors. The duration of follow-up was at least 24 months in all surviving patients. Outcome measures were the 5-year CLNR and overall survival rates. In the entire study cohort, the 5-year CLNR rate was 7% (55/913). Specifically, it was 18% (17/132) in patients with local recurrence (LR), and 5% (38/781) in those without (P = 0.0002). In multivariate analysis, extracapsular spread (ECS) was the only independent risk factor for CLNR in patients with LR. Tumor subsite, poor differentiation, and presence of pN + disease were significant predictors of CLNR in patients without LR. We identified two groups of patients with high CLNR rates. The first group consisted of patients with ECS at the initial diagnosis and LR. The second group consisted of subjects with tongue cancer without LR harboring at least two risk factors. We conclude that, in patients who achieved local control, postoperative contralateral neck treatment is recommended for subjects with tongue cancer and at least two risk factors. Once LR occurs, contralateral neck treatment is recommended in patients with ECS.
Literature
1.
go back to reference Woolgar JA. Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas. Br J Oral Maxillofac Surg. 1999;37:175–80.CrossRefPubMed Woolgar JA. Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas. Br J Oral Maxillofac Surg. 1999;37:175–80.CrossRefPubMed
2.
go back to reference Koo BS, Lim YC, Lee JS, et al. Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Head Neck. 2006;28:896–901.CrossRefPubMed Koo BS, Lim YC, Lee JS, et al. Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Head Neck. 2006;28:896–901.CrossRefPubMed
3.
go back to reference Kowalski LP, Bagietto R, Lara JR, et al. Factors influencing contralateral lymph node metastasis from oral carcinoma. Head Neck. 1999;21:104–10.CrossRefPubMed Kowalski LP, Bagietto R, Lara JR, et al. Factors influencing contralateral lymph node metastasis from oral carcinoma. Head Neck. 1999;21:104–10.CrossRefPubMed
4.
go back to reference Kurita H, Koike T, Narikawa JN, et al. Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol. 2004;40:898–903.CrossRefPubMed Kurita H, Koike T, Narikawa JN, et al. Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol. 2004;40:898–903.CrossRefPubMed
5.
go back to reference Lim YC, Lee JS, Koo BS, et al. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation. Laryngoscope. 2006;116:461–5.CrossRefPubMed Lim YC, Lee JS, Koo BS, et al. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation. Laryngoscope. 2006;116:461–5.CrossRefPubMed
6.
go back to reference Spiro RH, Alfonso AE, Farr HW, et al. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg. 1974;128:562–7.PubMed Spiro RH, Alfonso AE, Farr HW, et al. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg. 1974;128:562–7.PubMed
7.
go back to reference Kowalski LP, Bagietto R, Lara JR, et al. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck. 2000;22:207–14.CrossRefPubMed Kowalski LP, Bagietto R, Lara JR, et al. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck. 2000;22:207–14.CrossRefPubMed
8.
go back to reference Chow TL, Chow TK, Chan TT, et al. Contralateral neck recurrence of squamous cell carcinoma of oral cavity and oropharynx. J Oral Maxillofac Surg. 2004;62:1225–8.CrossRefPubMed Chow TL, Chow TK, Chan TT, et al. Contralateral neck recurrence of squamous cell carcinoma of oral cavity and oropharynx. J Oral Maxillofac Surg. 2004;62:1225–8.CrossRefPubMed
9.
go back to reference González-García R, Naval-Gías L, Sastre-Pérez J, et al. Contralateral lymph neck node metastasis of primary squamous cell carcinoma of the tongue: a retrospective analytic study of 203 patients. Int J Oral Maxillofac Surg. 2007;36:507–13.CrossRefPubMed González-García R, Naval-Gías L, Sastre-Pérez J, et al. Contralateral lymph neck node metastasis of primary squamous cell carcinoma of the tongue: a retrospective analytic study of 203 patients. Int J Oral Maxillofac Surg. 2007;36:507–13.CrossRefPubMed
10.
go back to reference González-García R, Naval-Gías L, Rodríguez-Campo FJ, et al. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients. J Oral Maxillofac Surg. 2008;66:1390–8.CrossRefPubMed González-García R, Naval-Gías L, Rodríguez-Campo FJ, et al. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients. J Oral Maxillofac Surg. 2008;66:1390–8.CrossRefPubMed
11.
go back to reference Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
12.
go back to reference Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, editors. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, editors. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.
13.
go back to reference Liao CT, Chang JT, Wang HM, et al. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer. 2006;107:337–44.CrossRefPubMed Liao CT, Chang JT, Wang HM, et al. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer. 2006;107:337–44.CrossRefPubMed
14.
go back to reference Liao CT, Ng SH, Chang JT, et al. T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol. 2007;43:570–9CrossRefPubMed Liao CT, Ng SH, Chang JT, et al. T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol. 2007;43:570–9CrossRefPubMed
15.
go back to reference Lin CY, Lee LY, Huang SF, et al. Treatment outcome of combined modalities for buccal cancers. Int J Radiat Oncol Biol Phys. 2008;70:1373–81.CrossRefPubMed Lin CY, Lee LY, Huang SF, et al. Treatment outcome of combined modalities for buccal cancers. Int J Radiat Oncol Biol Phys. 2008;70:1373–81.CrossRefPubMed
16.
go back to reference Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999–1004.CrossRefPubMed Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999–1004.CrossRefPubMed
17.
go back to reference Wang HM, Wang CS, Chen JS, et al. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002;94:2989–95.CrossRefPubMed Wang HM, Wang CS, Chen JS, et al. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002;94:2989–95.CrossRefPubMed
19.
go back to reference Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699–702.CrossRefPubMed Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699–702.CrossRefPubMed
20.
go back to reference Werner JA, Dunne AA, Myers JN. Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck. 2003;25:322–32.CrossRefPubMed Werner JA, Dunne AA, Myers JN. Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck. 2003;25:322–32.CrossRefPubMed
21.
go back to reference Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.CrossRefPubMed Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.CrossRefPubMed
22.
go back to reference Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.CrossRefPubMed Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.CrossRefPubMed
23.
go back to reference Bernier J, Cooper JS, Pajak TF, et al. D efining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843–50.CrossRefPubMed Bernier J, Cooper JS, Pajak TF, et al. D efining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843–50.CrossRefPubMed
Metadata
Title
Risk Stratification of Patients with Oral Cavity Squamous Cell Carcinoma and Contralateral Neck Recurrence Following Radical Surgery
Authors
Chun-Ta Liao
Shiang-Fu Huang
I-How Chen
Joseph Tung-Chieh Chang
Hung-Ming Wang
Shu-Hang Ng
Chuen Hsueh
Li-Yu Lee
Chih-Hung Lin
Ann-Joy Cheng
Tzu-Chen Yen
Publication date
01-01-2009
Publisher
Springer New York
Published in
Annals of Surgical Oncology / Issue 1/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0196-4

Other articles of this Issue 1/2009

Annals of Surgical Oncology 1/2009 Go to the issue